Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (362)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Editorial (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (942)
  2. Center for Hematologic Malignancies (942)
  3. Department of Medicine (942)
  4. Hematologic Malignancies, Division of (942)
  5. Survivorship Research (474)
  6. CTCR Scholars (411)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (204)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (30)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (264)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (942)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial disparities in access to alternative donor allografts persist in the era of "Donors for all"
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Nutrition as a predictor of microbiome injury in allo-HCT
    Meeting Abstract

    Dai, A.; Adintori, P. A.; Docampo, M. D.; Brambilla, C. Z.; Buchan, M. L.; Gomes, A. L.; Burgos da Silva, M. D.; Markey, K. A.; Devlin, S. M.; Clurman, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • MI-IMMUNE/1801: Lessons from an ongoing, multi-center trial involving biospecimen collection for prospective microbiome and immune profiling in patients undergoing reduced intensity conditioning allogeneic HCT
    Meeting Abstract

    Brooks, E.; Spahn, A.; Waldvogel, S.; Howard, A.; Bar, M.; Bratrude, B.; Chhabra, S.; Clark, W.; Das, S. R.; Horowitz, M. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells predict favorable outcome after allogeneic HCT and are supported by a diverse intestinal microbiome
    Meeting Abstract

    Andrlova, H.; Miltiadous, O.; Dai, A.; Gardner, R.; El Daker, S.; Slingerland, J. B.; Giardina, P. A.; Clurman, A.; Gomes, A. L. C.; Nguyen, C. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase 1/2 study of NEXI-001 donor-derived multi-antigen specific CD8+ T cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic transplantation
    Meeting Abstract

    Al Malki, M. M.; Vasu, S.; Modi, D.; Perales, M. A.; Ghoda, L. Y.; Bui, D.; Edavana, V.; Lu, E.; Kim, S.; Suarez, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species
    Journal Article

    Rolling, T.; Zhai, B.; Gjonbalaj, M.; Tosini, N.; Yasuma-Mitobe, K.; Fontana, E.; Amoretti, L. A.; Wright, R. J.; Ponce, D. M.; Perales, M. A.; more...
    Nature Microbiology (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US)
    Meeting Abstract

    Jacobson, C. A.; Locke, F. L.; Hu, Z. H.; Siddiqi, T.; Ahmed, S.; Ghobadi, A.; Miklos, D. B.; Lin, Y.; Perales, M. A.; Lunning, M. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Preliminary analysis of a phase 1/2 study of NEXI-001 donor-derived multi-antigen-specific CD8(+) T-cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Al Malki, M.; Vasu, S.; Modi, D.; Perales, M. A.; Bui, D.; Edavana, V.; Kim, S.; Suarez, L.; Oelke, M.; Bednárik, D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save